Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites

References

• Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191–7
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Hernandez Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570–6
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445–54
   PubMed Web of Science ®Google Scholar
• Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhension molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98:1–5
   PubMed Web of Science ®Google Scholar
• Klibanov AL, Hughes MS, Villanueva FS, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. Magma 1999;8:177–84
   PubMedGoogle Scholar
• Demos SM, Alkan-Onyuksel H, Kane BJ, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol 1999;33:867–75
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Ye RD. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol Therapeut 1997;74:73–102
   PubMed Web of Science ®Google Scholar
• Le Y, Yang Y, Cui Y, et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002;2:1–13
   PubMed Web of Science ®Google Scholar
• Crielaard BJ, Lammers T, Morgan ME, et al. Macrophages and liposomes in inflammatory disease: friends or foes? Int J Pharm 2011;416:499–506
   PubMed Web of Science ®Google Scholar
• Lasic DD. Doxorubicin in sterically stabilized liposomes. Nature 1996;380:561–2
   PubMed Web of Science ®Google Scholar
• Zhao XB, Muthusamy N, Byrd JC, Lee RJ. Cholesterol as a bilayer anchor for PEGylation and targeting ligands in folate-receptor-targeted liposomes. J Pharm Sci 2007;96:2424–39
   PubMed Web of Science ®Google Scholar
• Miller CR, Bondurant B, Mc Lean SD, et al. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 1998;37:12875–83
   PubMed Web of Science ®Google Scholar
• Parr MJ, Ansell SM, Choi LS, Cullis PR. Factors influencing the retention and chemical stability of poly (ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta 1994;1195:21–30
   PubMed Web of Science ®Google Scholar
• Qin Y, Fan W, Chen H, et al. In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes. J Drug Target 2010;18:536–49
   PubMed Web of Science ®Google Scholar
• Qin Y, Chen H, Zhang Q, et al. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Int J Pharm 2011;420:304–12
   PubMed Web of Science ®Google Scholar
• Maeda N, Takeuchi Y, Takada M, et al. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. J Control Release 2004;100:41–52
   PubMed Web of Science ®Google Scholar
• Han HD, Lee A, Song CK, et al. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int J Pharm 2006;313:181–8
   PubMed Web of Science ®Google Scholar
• Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982;155:264–75
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release 2010;145:178–81
   PubMed Web of Science ®Google Scholar
• Minafra L, Di Cara G, Albanese NN, Cancemi P. Proteomic differentiation pattern in the U937 cell line. Leukemia Res 2011;35:226–36
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang X, Pooyan S, et al. Optimizing size and copy number for PEG–fMLP (N-Formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages. Bioconjugate Chem 2008;19:28–38
   PubMed Web of Science ®Google Scholar
• Qin Y, Chen H, Yuan W, et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 2011;419:85–95
   PubMed Web of Science ®Google Scholar
• Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003;13:195–208
   PubMed Web of Science ®Google Scholar
• Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003;7:626–34
   PubMed Web of Science ®Google Scholar
• Xu RX, Young DC, Mao JJ, Povoski SP. A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions. Breast Cancer Res Tr 2007;9:R88
   Google Scholar
• Tromberg BJ, Pogue BW, Paulsen KD, et al. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008;35:243–51
   Google Scholar